| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phospholipid Transfer Proteins | 22 | 2017 | 88 | 6.090 |
Why?
|
| Thiolester Hydrolases | 14 | 2021 | 85 | 5.670 |
Why?
|
| Liver | 52 | 2023 | 7512 | 3.810 |
Why?
|
| Fatty Liver | 13 | 2023 | 777 | 2.810 |
Why?
|
| Fatty Acids | 19 | 2023 | 1805 | 2.210 |
Why?
|
| Lipid Metabolism | 21 | 2023 | 1902 | 2.170 |
Why?
|
| Triglycerides | 15 | 2023 | 2476 | 1.890 |
Why?
|
| Palmitoyl-CoA Hydrolase | 5 | 2021 | 17 | 1.820 |
Why?
|
| Cholesterol | 29 | 2016 | 2925 | 1.750 |
Why?
|
| Thermogenesis | 11 | 2021 | 468 | 1.570 |
Why?
|
| Bile Acids and Salts | 18 | 2019 | 380 | 1.410 |
Why?
|
| Insulin Resistance | 14 | 2021 | 3960 | 1.370 |
Why?
|
| Glucose | 14 | 2023 | 4361 | 1.250 |
Why?
|
| Energy Metabolism | 14 | 2021 | 2869 | 1.170 |
Why?
|
| Adipose Tissue, Brown | 12 | 2021 | 755 | 1.130 |
Why?
|
| Lipogenesis | 9 | 2023 | 210 | 1.050 |
Why?
|
| Phosphatidylcholines | 9 | 2023 | 406 | 1.030 |
Why?
|
| Lipoproteins | 8 | 2019 | 882 | 0.970 |
Why?
|
| Homeostasis | 9 | 2020 | 3305 | 0.790 |
Why?
|
| Mice, Knockout | 33 | 2021 | 14396 | 0.780 |
Why?
|
| Lipoproteins, VLDL | 4 | 2019 | 201 | 0.780 |
Why?
|
| Obesity | 19 | 2021 | 12915 | 0.710 |
Why?
|
| Mice | 69 | 2023 | 81216 | 0.700 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2019 | 34 | 0.680 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 2018 | 9 | 0.650 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 490 | 0.630 |
Why?
|
| Androgen-Binding Protein | 3 | 2002 | 10 | 0.620 |
Why?
|
| Animals | 89 | 2023 | 167940 | 0.620 |
Why?
|
| Hepatocytes | 11 | 2022 | 1228 | 0.550 |
Why?
|
| Mitochondrial Proteins | 4 | 2019 | 979 | 0.540 |
Why?
|
| Diet | 9 | 2023 | 8008 | 0.530 |
Why?
|
| Glucose Intolerance | 3 | 2017 | 579 | 0.510 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2023 | 2297 | 0.490 |
Why?
|
| Bile | 4 | 2005 | 296 | 0.490 |
Why?
|
| Mitochondria | 7 | 2021 | 3598 | 0.480 |
Why?
|
| Leptin | 5 | 2016 | 1590 | 0.480 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2015 | 104 | 0.470 |
Why?
|
| Dyslipidemias | 4 | 2016 | 895 | 0.460 |
Why?
|
| Anticholesteremic Agents | 2 | 2014 | 988 | 0.450 |
Why?
|
| PPAR alpha | 3 | 2010 | 174 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 26 | 2021 | 22025 | 0.450 |
Why?
|
| Calcium Signaling | 1 | 2017 | 731 | 0.430 |
Why?
|
| Fibroblast Growth Factors | 4 | 2021 | 867 | 0.430 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 147 | 0.420 |
Why?
|
| Apolipoproteins B | 1 | 2014 | 388 | 0.420 |
Why?
|
| Mouth Diseases | 1 | 2015 | 238 | 0.420 |
Why?
|
| Hypercholesterolemia | 5 | 2014 | 1155 | 0.410 |
Why?
|
| Fructose | 4 | 2019 | 287 | 0.400 |
Why?
|
| Lipoproteins, HDL | 3 | 2007 | 667 | 0.400 |
Why?
|
| ATP-Binding Cassette Transporters | 9 | 2014 | 563 | 0.400 |
Why?
|
| Liver Neoplasms | 4 | 2023 | 4317 | 0.390 |
Why?
|
| Insulin | 7 | 2023 | 6592 | 0.390 |
Why?
|
| Mice, Obese | 4 | 2017 | 420 | 0.390 |
Why?
|
| Pruritus | 1 | 2015 | 377 | 0.380 |
Why?
|
| Acyl Coenzyme A | 2 | 2020 | 57 | 0.380 |
Why?
|
| Oligonucleotides | 1 | 2014 | 588 | 0.380 |
Why?
|
| Oxidation-Reduction | 5 | 2021 | 2222 | 0.370 |
Why?
|
| Carrier Proteins | 8 | 2018 | 4938 | 0.360 |
Why?
|
| Calorimetry, Indirect | 4 | 2018 | 174 | 0.330 |
Why?
|
| Fruit | 1 | 2015 | 1162 | 0.330 |
Why?
|
| Vegetables | 1 | 2015 | 1198 | 0.330 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 5 | 2008 | 28 | 0.310 |
Why?
|
| Adipose Tissue, White | 6 | 2019 | 365 | 0.310 |
Why?
|
| Gene Deletion | 3 | 2013 | 2668 | 0.310 |
Why?
|
| Allylamine | 1 | 2007 | 10 | 0.300 |
Why?
|
| Gallstones | 3 | 2008 | 283 | 0.300 |
Why?
|
| Mice, Inbred Strains | 5 | 2016 | 1765 | 0.300 |
Why?
|
| Intestines | 1 | 2016 | 1907 | 0.290 |
Why?
|
| Phospholipids | 4 | 2007 | 789 | 0.290 |
Why?
|
| Food Hypersensitivity | 1 | 2015 | 692 | 0.290 |
Why?
|
| Calcium | 2 | 2017 | 5726 | 0.280 |
Why?
|
| Mice, Inbred NZB | 1 | 2006 | 57 | 0.280 |
Why?
|
| Paired Box Transcription Factors | 1 | 2007 | 207 | 0.280 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 4923 | 0.270 |
Why?
|
| Gluconeogenesis | 2 | 2020 | 185 | 0.270 |
Why?
|
| Thyroid Hormones | 3 | 2021 | 403 | 0.260 |
Why?
|
| Glucose Tolerance Test | 4 | 2016 | 1174 | 0.260 |
Why?
|
| Dietary Fats | 6 | 2014 | 1992 | 0.250 |
Why?
|
| Arrestins | 2 | 2017 | 73 | 0.240 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 3333 | 0.240 |
Why?
|
| Apolipoprotein A-I | 2 | 2005 | 297 | 0.230 |
Why?
|
| Macrophages, Peritoneal | 1 | 2005 | 237 | 0.230 |
Why?
|
| Body Weight | 4 | 2021 | 4613 | 0.230 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2017 | 241 | 0.230 |
Why?
|
| Liver Failure | 1 | 2006 | 249 | 0.220 |
Why?
|
| Rosacea | 1 | 2024 | 59 | 0.220 |
Why?
|
| PPAR delta | 1 | 2023 | 40 | 0.220 |
Why?
|
| Lipids | 8 | 2017 | 3336 | 0.220 |
Why?
|
| Biological Transport | 5 | 2017 | 2087 | 0.210 |
Why?
|
| Enterohepatic Circulation | 1 | 2002 | 12 | 0.210 |
Why?
|
| Cholesterol, HDL | 4 | 2015 | 1817 | 0.210 |
Why?
|
| Apolipoproteins E | 2 | 2015 | 1437 | 0.200 |
Why?
|
| High-Throughput Screening Assays | 2 | 2023 | 943 | 0.200 |
Why?
|
| Weight Loss | 4 | 2018 | 2683 | 0.190 |
Why?
|
| Nobel Prize | 1 | 2021 | 48 | 0.190 |
Why?
|
| Zebrafish Proteins | 2 | 2019 | 1006 | 0.190 |
Why?
|
| Program Development | 1 | 2007 | 1297 | 0.180 |
Why?
|
| Male | 40 | 2023 | 359413 | 0.180 |
Why?
|
| Fibrinogen | 2 | 2015 | 887 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 824 | 0.180 |
Why?
|
| Lysophosphatidylcholines | 1 | 2020 | 77 | 0.180 |
Why?
|
| Body Temperature | 2 | 2016 | 777 | 0.180 |
Why?
|
| Up-Regulation | 4 | 2021 | 4127 | 0.170 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2019 | 114 | 0.160 |
Why?
|
| Alanine Transaminase | 2 | 2016 | 607 | 0.160 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2018 | 43 | 0.160 |
Why?
|
| Eating | 2 | 2016 | 1538 | 0.160 |
Why?
|
| Glycerides | 1 | 2018 | 67 | 0.160 |
Why?
|
| Gene Expression Regulation | 11 | 2017 | 11902 | 0.160 |
Why?
|
| Myostatin | 1 | 2020 | 127 | 0.160 |
Why?
|
| Humans | 53 | 2024 | 760261 | 0.160 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 3 | 2002 | 8 | 0.160 |
Why?
|
| Protein Phosphatase 1 | 1 | 2018 | 135 | 0.150 |
Why?
|
| Adiposity | 4 | 2021 | 1851 | 0.150 |
Why?
|
| Blood Glucose | 4 | 2017 | 6375 | 0.150 |
Why?
|
| Membrane Fluidity | 1 | 2017 | 68 | 0.150 |
Why?
|
| Overnutrition | 1 | 2017 | 25 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 2 | 2023 | 907 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2018 | 180 | 0.150 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 7 | 1 | 2016 | 4 | 0.140 |
Why?
|
| Bariatric Surgery | 3 | 2016 | 1006 | 0.140 |
Why?
|
| Animal Feed | 1 | 2017 | 112 | 0.140 |
Why?
|
| Glutamine | 2 | 2017 | 576 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 173 | 0.140 |
Why?
|
| Pyruvates | 1 | 2016 | 84 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2023 | 1109 | 0.140 |
Why?
|
| Cholesterol, LDL | 3 | 2015 | 2422 | 0.140 |
Why?
|
| Lipolysis | 1 | 2017 | 211 | 0.140 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 6543 | 0.140 |
Why?
|
| Atherosclerosis | 3 | 2008 | 3524 | 0.140 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2018 | 256 | 0.130 |
Why?
|
| Animal Experimentation | 1 | 2016 | 46 | 0.130 |
Why?
|
| Cold Temperature | 1 | 2020 | 780 | 0.130 |
Why?
|
| Hyperammonemia | 1 | 2017 | 77 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 3800 | 0.130 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 159 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 4286 | 0.130 |
Why?
|
| Cholelithiasis | 2 | 2010 | 408 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 2018 | 548 | 0.120 |
Why?
|
| Gastrointestinal Contents | 1 | 2015 | 42 | 0.120 |
Why?
|
| Oxygen Consumption | 2 | 2013 | 1840 | 0.120 |
Why?
|
| Choline | 1 | 2017 | 513 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2016 | 2861 | 0.120 |
Why?
|
| Protein Binding | 5 | 2018 | 9336 | 0.120 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2020 | 840 | 0.120 |
Why?
|
| Mice, Transgenic | 6 | 2013 | 9531 | 0.120 |
Why?
|
| Methionine | 1 | 2017 | 569 | 0.120 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2014 | 21 | 0.120 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2014 | 28 | 0.120 |
Why?
|
| Consensus | 1 | 2024 | 3106 | 0.120 |
Why?
|
| Receptors, LDL | 2 | 2015 | 491 | 0.120 |
Why?
|
| Hepacivirus | 1 | 2021 | 1333 | 0.120 |
Why?
|
| Intestinal Mucosa | 5 | 2015 | 3023 | 0.120 |
Why?
|
| Substrate Specificity | 2 | 2009 | 1792 | 0.120 |
Why?
|
| Panniculitis | 1 | 2014 | 45 | 0.110 |
Why?
|
| Liver Diseases | 3 | 2018 | 1301 | 0.110 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2016 | 366 | 0.110 |
Why?
|
| Body Composition | 4 | 2017 | 2418 | 0.110 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 2 | 2004 | 60 | 0.110 |
Why?
|
| Societies, Medical | 2 | 2015 | 3903 | 0.110 |
Why?
|
| Phosphoproteins | 2 | 2016 | 2441 | 0.110 |
Why?
|
| Workflow | 1 | 2018 | 851 | 0.110 |
Why?
|
| Receptors, Thrombin | 1 | 2013 | 132 | 0.110 |
Why?
|
| Natural Killer T-Cells | 1 | 2016 | 311 | 0.110 |
Why?
|
| Transcription Factors | 7 | 2023 | 12100 | 0.110 |
Why?
|
| Mucus | 1 | 2015 | 338 | 0.110 |
Why?
|
| Receptors, CXCR3 | 1 | 2014 | 238 | 0.110 |
Why?
|
| Coma | 1 | 2017 | 487 | 0.110 |
Why?
|
| MicroRNAs | 3 | 2015 | 3784 | 0.110 |
Why?
|
| Cross Reactions | 1 | 2015 | 818 | 0.110 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 4172 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 465 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3086 | 0.100 |
Why?
|
| Species Specificity | 2 | 2007 | 2413 | 0.100 |
Why?
|
| Kinetics | 3 | 2020 | 6378 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3206 | 0.100 |
Why?
|
| Double-Blind Method | 3 | 2019 | 12412 | 0.100 |
Why?
|
| Inhalation Exposure | 1 | 2015 | 429 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 12281 | 0.100 |
Why?
|
| Estrogens | 1 | 2019 | 1520 | 0.100 |
Why?
|
| Adipocytes | 3 | 2019 | 1179 | 0.100 |
Why?
|
| Signal Transduction | 9 | 2020 | 23363 | 0.100 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 147 | 0.100 |
Why?
|
| Estradiol | 1 | 2019 | 1932 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 1189 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2019 | 2058 | 0.100 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 663 | 0.090 |
Why?
|
| Hepatitis C | 1 | 2021 | 1578 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1244 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2018 | 1395 | 0.090 |
Why?
|
| Models, Molecular | 3 | 2007 | 5429 | 0.090 |
Why?
|
| Feeding Behavior | 2 | 2021 | 3185 | 0.090 |
Why?
|
| Malnutrition | 1 | 2017 | 638 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2013 | 393 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2202 | 0.090 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2010 | 25 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 685 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2009 | 5039 | 0.090 |
Why?
|
| Crosses, Genetic | 2 | 2009 | 751 | 0.090 |
Why?
|
| Adipose Tissue | 4 | 2015 | 3293 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1843 | 0.090 |
Why?
|
| Liver Function Tests | 2 | 2014 | 524 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2010 | 119 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2013 | 839 | 0.080 |
Why?
|
| Fenofibrate | 1 | 2010 | 88 | 0.080 |
Why?
|
| Gaucher Disease | 1 | 2010 | 110 | 0.080 |
Why?
|
| Iodide Peroxidase | 1 | 2011 | 294 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6499 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 2509 | 0.080 |
Why?
|
| Apoptosis | 1 | 2005 | 9497 | 0.080 |
Why?
|
| Membrane Proteins | 4 | 2022 | 7854 | 0.080 |
Why?
|
| Cell Membrane | 3 | 2010 | 3683 | 0.080 |
Why?
|
| Protein Folding | 2 | 2009 | 867 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 18134 | 0.080 |
Why?
|
| Base Sequence | 2 | 2012 | 12447 | 0.080 |
Why?
|
| Osmolar Concentration | 1 | 2009 | 662 | 0.080 |
Why?
|
| Chylomicrons | 1 | 2007 | 26 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 8058 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2014 | 18968 | 0.080 |
Why?
|
| Biliary Tract | 1 | 2008 | 135 | 0.080 |
Why?
|
| Microscopy, Electron | 2 | 2009 | 2558 | 0.070 |
Why?
|
| Tissue Distribution | 3 | 2007 | 2262 | 0.070 |
Why?
|
| Steroid Hydroxylases | 2 | 2004 | 96 | 0.070 |
Why?
|
| Glucose Clamp Technique | 1 | 2008 | 263 | 0.070 |
Why?
|
| Lipoprotein-X | 1 | 2007 | 5 | 0.070 |
Why?
|
| DNA Primers | 1 | 2012 | 2819 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2021 | 8314 | 0.070 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2007 | 84 | 0.070 |
Why?
|
| Fibrosis | 1 | 2014 | 2042 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 2 | 2010 | 1135 | 0.070 |
Why?
|
| Gallbladder | 2 | 2005 | 305 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 1120 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3764 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 3774 | 0.070 |
Why?
|
| Pulmonary Surfactants | 1 | 2007 | 161 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2009 | 900 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 458 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2823 | 0.070 |
Why?
|
| Temperature | 2 | 2011 | 2221 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2008 | 854 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2014 | 1811 | 0.070 |
Why?
|
| Cardiovascular Diseases | 4 | 2016 | 15740 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2895 | 0.060 |
Why?
|
| Ligands | 2 | 2023 | 3277 | 0.060 |
Why?
|
| Logistic Models | 1 | 2020 | 13311 | 0.060 |
Why?
|
| Female | 19 | 2020 | 391011 | 0.060 |
Why?
|
| Lactation | 1 | 2008 | 395 | 0.060 |
Why?
|
| Cholesterol, Dietary | 1 | 2005 | 224 | 0.060 |
Why?
|
| Bile Canaliculi | 1 | 2004 | 11 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 929 | 0.060 |
Why?
|
| Bezafibrate | 1 | 2004 | 14 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4573 | 0.060 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2005 | 85 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3804 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4409 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 415 | 0.060 |
Why?
|
| CHO Cells | 2 | 2010 | 1389 | 0.060 |
Why?
|
| RNA, Messenger | 6 | 2011 | 12762 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2005 | 412 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4264 | 0.060 |
Why?
|
| Infusions, Parenteral | 1 | 2004 | 404 | 0.060 |
Why?
|
| Cholestasis | 1 | 2007 | 374 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2009 | 1663 | 0.060 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2003 | 74 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 9388 | 0.050 |
Why?
|
| Cricetinae | 2 | 2010 | 2427 | 0.050 |
Why?
|
| Enzyme Induction | 2 | 2017 | 452 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2006 | 1993 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 2804 | 0.050 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2022 | 11 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1746 | 0.050 |
Why?
|
| Prognosis | 2 | 2013 | 29636 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2013 | 2522 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2007 | 1895 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2007 | 1955 | 0.050 |
Why?
|
| Biopsy | 1 | 2014 | 6775 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1297 | 0.050 |
Why?
|
| Cell Line | 3 | 2019 | 15626 | 0.050 |
Why?
|
| Cholesterol, VLDL | 1 | 2002 | 71 | 0.050 |
Why?
|
| Caveolins | 1 | 2002 | 102 | 0.050 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2002 | 260 | 0.050 |
Why?
|
| Intestinal Absorption | 1 | 2003 | 401 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1737 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2651 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2015 | 8157 | 0.050 |
Why?
|
| Homozygote | 1 | 2006 | 1786 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2008 | 2918 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2004 | 543 | 0.050 |
Why?
|
| X-Ray Diffraction | 1 | 2002 | 420 | 0.050 |
Why?
|
| Adrenergic Agonists | 1 | 2021 | 58 | 0.050 |
Why?
|
| Cattle | 1 | 2007 | 3847 | 0.050 |
Why?
|
| Point Mutation | 1 | 2006 | 1594 | 0.050 |
Why?
|
| Crystallization | 1 | 2002 | 533 | 0.050 |
Why?
|
| Organ Size | 2 | 2019 | 2249 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8641 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2010 | 1858 | 0.050 |
Why?
|
| Acyltransferases | 1 | 2022 | 306 | 0.050 |
Why?
|
| Middle Aged | 7 | 2020 | 220175 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 9590 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2005 | 1690 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2021 | 197 | 0.040 |
Why?
|
| Lipase | 1 | 2022 | 324 | 0.040 |
Why?
|
| Research Design | 1 | 2016 | 6181 | 0.040 |
Why?
|
| Consultants | 1 | 2020 | 53 | 0.040 |
Why?
|
| Liver Transplantation | 2 | 2014 | 2317 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 58 | 0.040 |
Why?
|
| Growth Differentiation Factors | 1 | 2020 | 99 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8498 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 317 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2004 | 2235 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2002 | 1230 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 5793 | 0.040 |
Why?
|
| Risk Factors | 3 | 2020 | 74269 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 64947 | 0.040 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 3696 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2020 | 426 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12968 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 24086 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2005 | 1617 | 0.040 |
Why?
|
| Protein Transport | 1 | 2004 | 1966 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2006 | 3969 | 0.040 |
Why?
|
| Macrophages | 3 | 2010 | 5745 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 1892 | 0.040 |
Why?
|
| United States | 4 | 2020 | 72363 | 0.040 |
Why?
|
| Cytosol | 1 | 2001 | 887 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 82 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4625 | 0.040 |
Why?
|
| Fructokinases | 1 | 2017 | 6 | 0.040 |
Why?
|
| New York | 1 | 2020 | 874 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 126 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10757 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2018 | 149 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 1979 | 0.040 |
Why?
|
| tRNA Methyltransferases | 1 | 2017 | 52 | 0.040 |
Why?
|
| Sodium Benzoate | 1 | 2017 | 15 | 0.040 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2017 | 79 | 0.040 |
Why?
|
| Disease Progression | 1 | 2014 | 13505 | 0.040 |
Why?
|
| Serine | 1 | 2021 | 831 | 0.040 |
Why?
|
| Phenylacetates | 1 | 2017 | 113 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 2019 | 213 | 0.040 |
Why?
|
| Haplorhini | 1 | 2018 | 529 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 363 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 17766 | 0.030 |
Why?
|
| Rats | 3 | 2015 | 23695 | 0.030 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2018 | 378 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2008 | 2567 | 0.030 |
Why?
|
| Zebrafish | 2 | 2019 | 2996 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3601 | 0.030 |
Why?
|
| Aged | 4 | 2020 | 168995 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2015 | 45 | 0.030 |
Why?
|
| Glutamates | 1 | 2017 | 391 | 0.030 |
Why?
|
| Deficiency Diseases | 1 | 2016 | 74 | 0.030 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2015 | 59 | 0.030 |
Why?
|
| Digestion | 1 | 2015 | 54 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 2015 | 100 | 0.030 |
Why?
|
| Weight Gain | 2 | 2019 | 2347 | 0.030 |
Why?
|
| Endocrine System | 1 | 2015 | 112 | 0.030 |
Why?
|
| Sex Factors | 3 | 2019 | 10530 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 688 | 0.030 |
Why?
|
| Viscosity | 1 | 2015 | 335 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2008 | 400 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2015 | 210 | 0.030 |
Why?
|
| Embolism, Cholesterol | 1 | 2013 | 33 | 0.030 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2014 | 63 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 114 | 0.030 |
Why?
|
| Transfection | 1 | 2001 | 5782 | 0.030 |
Why?
|
| Binding Sites | 1 | 2002 | 6050 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2021 | 2777 | 0.030 |
Why?
|
| Diarrhea | 1 | 2020 | 1341 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1897 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 402 | 0.030 |
Why?
|
| ROC Curve | 1 | 2020 | 3568 | 0.030 |
Why?
|
| Adult | 4 | 2019 | 219847 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 389 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 2012 | 78 | 0.030 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2014 | 172 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10434 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2012 | 224 | 0.020 |
Why?
|
| Iceland | 1 | 2011 | 184 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 1977 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 1553 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 1755 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2020 | 6361 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10829 | 0.020 |
Why?
|
| Glucosylceramides | 1 | 2010 | 28 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2003 | 3389 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2010 | 56 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2013 | 805 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2011 | 385 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8621 | 0.020 |
Why?
|
| Gene Expression | 2 | 2019 | 7592 | 0.020 |
Why?
|
| Food | 1 | 2015 | 772 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 26912 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2011 | 345 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1135 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2010 | 135 | 0.020 |
Why?
|
| Models, Animal | 1 | 2016 | 2117 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2002 | 4223 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2018 | 6242 | 0.020 |
Why?
|
| Time Factors | 3 | 2014 | 40133 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 13456 | 0.020 |
Why?
|
| Intestine, Small | 2 | 2007 | 1207 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 2008 | 1791 | 0.020 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2008 | 9 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 815 | 0.020 |
Why?
|
| Cholic Acids | 1 | 2008 | 39 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2017 | 826 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 1925 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2016 | 1861 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5876 | 0.020 |
Why?
|
| Ketones | 1 | 2009 | 183 | 0.020 |
Why?
|
| Virus Diseases | 1 | 2014 | 721 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 514 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8805 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2010 | 459 | 0.020 |
Why?
|
| Ion Channels | 1 | 2012 | 1043 | 0.020 |
Why?
|
| Introns | 1 | 2010 | 978 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 2755 | 0.020 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2007 | 33 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2449 | 0.020 |
Why?
|
| Integrases | 1 | 2009 | 516 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 1603 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 1996 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5420 | 0.020 |
Why?
|
| Enterocytes | 1 | 2007 | 220 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2007 | 1544 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7593 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3613 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 1882 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 5902 | 0.020 |
Why?
|
| Incidence | 2 | 2016 | 21378 | 0.020 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 2004 | 21 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 2494 | 0.020 |
Why?
|
| Lysosomes | 1 | 2010 | 919 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2013 | 1380 | 0.010 |
Why?
|
| Glycolysis | 1 | 2008 | 828 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2008 | 836 | 0.010 |
Why?
|
| Models, Biological | 2 | 2010 | 9468 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 2008 | 893 | 0.010 |
Why?
|
| Sterols | 1 | 2003 | 62 | 0.010 |
Why?
|
| Body Mass Index | 2 | 2011 | 12901 | 0.010 |
Why?
|
| Gastrointestinal Transit | 1 | 2003 | 99 | 0.010 |
Why?
|
| Detergents | 1 | 2002 | 235 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2011 | 2618 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2014 | 3061 | 0.010 |
Why?
|
| RNA Interference | 1 | 2010 | 2846 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12532 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14656 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 514 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 5784 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2002 | 257 | 0.010 |
Why?
|
| Hospitalization | 1 | 2020 | 10761 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20048 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3443 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15827 | 0.010 |
Why?
|
| Phenotype | 2 | 2010 | 16543 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 908 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 2702 | 0.010 |
Why?
|
| Thrombosis | 1 | 2013 | 3052 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 704 | 0.010 |
Why?
|
| Capillaries | 1 | 2002 | 745 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2002 | 674 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2002 | 768 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 1084 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2011 | 41317 | 0.010 |
Why?
|
| Integrins | 1 | 2002 | 840 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 29950 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 36247 | 0.010 |
Why?
|
| Microcirculation | 1 | 2002 | 1279 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12602 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 15766 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 29725 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 58947 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11064 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 15687 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3726 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 80301 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54263 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 4437 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 12959 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 87747 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 16905 | 0.000 |
Why?
|
| Lung | 1 | 2002 | 9989 | 0.000 |
Why?
|